Evidence map›Paper›PMID 24371030›Full record

Trial reportAJNR. American journal of neuroradiology2014

CTA collateral status and response to recanalization in patients with acute ischemic stroke.

V Nambiar, S I Sohn, M A Almekhlafi, H W Chang, S Mishra, E Qazi, M Eesa, A M Demchuk, M Goyal, M D Hill and 1 more

Abstract readClinical Trial
In one paragraph

Trial report in AJNR. American journal of neuroradiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Under (back) pressure: Better collateral flow may facilitate clot removal in ischemic stroke: A systematic review and meta-analysis.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Pooled it
  2. Pooled it
  3. Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Trial
  4. Collateral status and tissue outcome after intra-arterial therapy for patients with acute ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The negative effect of aging on cerebral venous outflow in acute ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Clinical and radiological factors predicting stroke outcome after successful mechanical intervention in anterior circulation.European heart journal supplements : journal of the European Society of Cardiology · 2022
    Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

V NambiarFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.).
S I SohnDepartments of Neurology (S.I.S.).
M A AlmekhlafiFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Department of Internal Medicine (M.A.A.), King Abdulaziz University, Jeddah, Saudi Arabia.
H W ChangRadiology (H.W.C.), Brain Research Institute, Keimyung University, Daegu, South Korea.
S MishraFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.).
E QaziFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.).
M EesaFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.).
A M DemchukFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.)Hotchkiss Brain Institute (A.M.D., M.G., M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, Canada.
M GoyalFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.)Hotchkiss Brain Institute (A.M.D., M.G., M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, Canada.
M D HillFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.)Community Health Sciences (M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, CanadaHotchkiss Brain Institute (A.M.D., M.G., M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, Canada.
B K MenonFrom the Calgary Stroke Program, Departments of Clinical Neurosciences (V.N., M.A.A., S.M., E.Q., M.E., A.M.D., M.G., M.D.H., B.K.M.)Radiology (M.E., A.M.D., M.G., M.D.H., B.K.M.)Community Health Sciences (M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, CanadaHotchkiss Brain Institute (A.M.D., M.G., M.D.H., B.K.M.), University of Calgary, Calgary, Alberta, Canada. docbijoymenon@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeCollateral status at baseline is an independent determinant of clinical outcome among patients with acute ischemic stroke. We sought to identify whether the association between recanalization after intra-arterial acute stroke therapy and favorable clinical response is modified by the presence of good collateral flow assessed on baseline CTA. MATERIALS AND

methodsData are from the Keimyung Stroke Registry, a prospective cohort study of patients with acute ischemic stroke from Daegu, South Korea. Patients with M1 segment MCA with or without intracranial ICA occlusions on baseline CTA from May 2004 to July 2009 who also had baseline MR imaging were included. Two readers blinded to all clinical information assessed baseline and follow-up imaging. Leptomeningeal collaterals on baseline CTA were assessed by consensus by use of the regional leptomeningeal score.

resultsAmong 84 patients (mean age, 65.2 ± 13.2 years; median NIHSS score, 14; interquartile range, 8.5), median time from stroke onset to initial MR imaging was 164 minutes. TICI 2b-3 recanalization was achieved in 38.1% of patients and mRS 0-2 at 90 days in 35.8% of patients. In a multivariable model, the interaction between collateral status and recanalization was significant. Only patients with intermediate or good collaterals who recanalized showed a statistically significant association with good clinical outcome (rate ratio = 3.8; 95% CI, 1.2-12.1). Patients with good and intermediate collaterals who did not achieve recanalization and patients with poor collaterals, even if they achieved recanalization, did not do well.

conclusionsPatients with good or intermediate collaterals on CTA benefit from intra-arterial therapy, whereas patients with poor collaterals do not benefit from treatment.

Indexed as

Cerebral RevascularizationAgedBrain IschemiaCerebral AngiographyCerebral ArteriesFemaleHumansMaleReproducibility of ResultsSensitivity and SpecificityStrokeTomography, X-Ray ComputedTreatment Outcome

Identifiers

PMID24371030
PMCPMC7964545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.